B7-H3 and CSPG4 co-targeting as Pan-CAR-T cell treatment of triple-negative breast cancer
These data highlight the clinical potential of the proposed approach that could be applicable to the great majority of patients with TNBC as well as most of patients with breast cancer in general.
Authors
- Roberto Borea (ORCID: https://orcid.org/0000-0001-5403-0916)
- Gianpietro Dotti (ORCID: https://orcid.org/0000-0002-2639-8526)
- Susana García‐Recio (ORCID: https://orcid.org/0000-0003-3820-1679)
- Elena Camerini (ORCID: https://orcid.org/0000-0002-9885-456X)
- Siobhán O’Connor (ORCID: https://orcid.org/0000-0001-7218-3270)
- Lisa A. Carey (ORCID: https://orcid.org/0000-0003-2388-4649)
- Patrick D. Rädler (ORCID: https://orcid.org/0000-0003-1543-7478)
- H Shelton Earp
- Charles M. Perou (ORCID: https://orcid.org/0000-0001-9827-2247)
- Barbara Savoldo (ORCID: https://orcid.org/0000-0002-7571-3887)
- Simone Stucchi (ORCID: https://orcid.org/0000-0003-3315-9205)
- Caroline Marnata Pellegry
- Manuela Zingarelli
Institutions
- University of North Carolina at Chapel Hill (US)
- UNC Lineberger Comprehensive Cancer Center
Publication Details
- Journal
- Journal for ImmunoTherapy of Cancer
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1136/jitc-2025-011533
- Citations
- 8
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 8.36